Recombinant Human AADAC Protein (Baculovirus)，His

AADAC (avian adenosine deaminase associated with RNA-1) is a member of the adenosine deaminase family and plays a significant role in modulating various biological processes, including RNA metabolism and immune response. Recent studies have highlighted its potential implications in diseases such as cancer and neurodegenerative disorders, due to its involvement in adenosine signaling pathways, which are critical for cellular communication and homeostasis. Moreover, AADAC has been implicated in drug metabolism, particularly in the context of certain therapeutic agents, influencing the pharmacokinetics and efficacy of these drugs. The recombinant expression of AADAC protein has been explored to facilitate in-depth functional studies, enabling researchers to investigate its structure-function relationships, enzymatic activities, and interactions with other molecular partners. This approach not only aids in elucidating the mechanistic roles of AADAC in pathological conditions but also paves the way for potential therapeutic applications, such as designing inhibitors or modulators that can target its enzymatic function. Understanding the biochemistry and biological functions of AADAC through recombinant protein research is essential for developing innovative strategies to manipulate adenosine-related pathways in various clinical settings, thereby providing new avenues for treatment strategies and improving patient outcomes.